@immunofighters.bsky.social
El grupo de Inmunología Tumoral descubre una nueva molécula con valor pronóstico y terapéutico en leucemia: LILRB4👨🔬
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of clonal malignant B cells and heterogeneous clinical outcomes. This study ex…
www.sciencedirect.com
July 11, 2025 at 11:08 AM
El grupo de Inmunología Tumoral descubre una nueva molécula con valor pronóstico y terapéutico en leucemia: LILRB4👨🔬
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...